In drug discovery trials, the potential for a molecule to do harm to an organism must be known accurately. Understanding how a substance under investigation behaves once in the body informs the design ...

The brain is the most advanced organ with various complex structural and functional microregions. It is often challenging to understand what and where the molecular events would occur for a given drug ...

When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens if the dosage ...

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer This longitudinal study linked pharmacokinetic assays collected ...

BUFFALO, N.Y. — When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens ...

Targeted protein degradation offers a way to test drug targets before costly drug development begins. Here, the authors benchmark tag-degrader systems in mice, identify dTAG as the most effective ...

A phase 1/2a, multicenter, first-in-human, open-label clinical trial evaluating MDX2004 monotherapy in patients with advanced tumors. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting ...

The agency releases guidance on the use of pharmacokinetics and pharmacodynamics analyses in the development of antibiotics. The European Medicines Agency (EMA) has released a guideline on the ...

EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) ...

Novigenix AI Liquid Biopsy Platform Identifies Immune Activation Patterns Associated with Radioligand Therapy Response in Gastroenteropancreatic Neuroendocrine Tumors Novigenix AI, a leader in ...